MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

14 Feb 2023 Evaluate
The sales declined to Rs. 976.46 millions for the December 2022 quarter as compared to Rs. 1106.96 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 107.11 millions from Rs. 205.78 millions, a decline of -47.95% on QoQ basis.The Operating Profit of the company witnessed a decrease to 158.34 millions from 288.22 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 976.46 1106.96 -11.79 2793.19 2992.90 -6.67 4058.42 3328.44 21.93
Other Income 36.77 31.98 14.98 97.21 102.22 -4.90 153.83 113.20 35.89
PBIDT 158.34 288.22 -45.06 411.37 733.42 -43.91 948.56 860.73 10.20
Interest 0.16 0.30 -46.67 0.60 1.84 -67.39 4.85 5.00 -3.00
PBDT 158.18 287.92 -45.06 410.77 731.58 -43.85 943.71 855.73 10.28
Depreciation 13.14 8.77 49.83 39.02 26.02 49.96 37.95 36.70 3.41
PBT 145.04 279.15 -48.04 371.75 705.56 -47.31 905.76 819.03 10.59
TAX 37.93 73.37 -48.30 100.36 180.74 -44.47 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 107.11 205.78 -47.95 271.39 524.82 -48.29 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 16.22 26.04 -37.72 14.73 24.51 -39.90 23.37 25.86 -9.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..